missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. PEP0507

Invitrogen™ Human IFN beta Synthetic Peptide

Numéro de catalogue. PEP0507
Change view
Click to view available options
Quantity:
50 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Numéro de catalogue. Quantity
PEP0507 50 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Numéro de catalogue. PEP0507 Fournisseur Invitrogen™ Code fournisseur PEP0507
Il en reste null

Description

Synthetic Peptide

IFN-beta Synthetic Peptide, PEP-0507, from Invitrogen.

Type I Interferons (IFN-alpha/beta) are produced primarily in response to viral infection by Natural IFN-producing cells (IPCs) as part of the host immune response. IFNs can also inhibit the development of tumors. IFN-beta binding results in the activation of the tyrosine kinases Jak1 and Tyk2, phosphorylation of members of the STAT family of transcription factors, and the transcription and expression of the immune response genes. More recently, several members of the toll-like receptor (TLR) family were found to stimulate the production IFN-beta. IFN-beta is currently used clinically for treatment of tumors, infections and multiple sclerosis.

Spécifications

Gene ID (Entrez) 3456
Species Human
Purification Method purified
Accession Number P01574
Common Name Human IFN beta
Concentration 1 mg/mL
Content And Storage -20°C
Description Synthetic Peptide
Format Liquid
Formulation PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For Use With (Application) Blocking Assay, Control
Gene Symbol IFNB1
Lyophilized No
Preservative 0.02% sodium azide
Product Type Peptide
Quantity 50 μg
Regulatory Status RUO - research use only
Storage Buffer PBS
Afficher plus de résultats Afficher moins de résultats